Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy (NCT07405645)
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy for Pain Palliation in Head, Neck, & Brachial Cancer
🩺 Plain-English Summary (8th-Grade Level)
This phase 1 multi-site study investigates the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer and brachial cancer.
Who can join: Review the eligibility criteria below.
Location: Brigham and Women's Hospital — Boston, Massachusetts
Age range: 18 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Brigham and Women's Hospital — Boston, Massachusetts
- Weill Cornell Medicine — New York, New York
- Oregon Health and Science University — Portland, Oregon
- The University of Texas Southwestern Medical Center — Dallas, Texas
- Baylor College of Medicine — Houston, Texas
- University of Virginia — Charlottesville, Virginia
📞 Contact the Study Coordinator
Phone: (434) 924-0451
Email: wje4r@uvahealth.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Head Neck Cancer
- First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients — Winston-Salem, North Carolina
- Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery — Montreal, Quebec
- Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer — Chicago, Illinois
Explore by condition: All Head Neck Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.